Oncotherapy Science

Basic Information

Stock Code
4564
Industry
Pharmaceuticals
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Kanagawa Prefecture
Establishment Year
April 2001
Listing Year
December 2003
Official Website
https://www.oncotherapy.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
GNI Group, Heartseed, Nexel Pharma, PeptiDream, Ribomic, SanBio, Helios, BrightPath, Solasia, RenaScience, QualiPs, Takara Bio, Japan Tissue Engineering

Overview

Oncotherapy Science is a Japanese drug discovery venture founded in 2001, specializing in the development of gene-related pharmaceuticals such as cancer treatment vaccines, with strengths in joint research with universities and partnerships with pharmaceutical companies.

Current Situation

As of 2023, Oncotherapy Science has consolidated sales of approximately 5.2 billion yen and is a university-spun venture in the biotech pharmaceuticals sector focusing on cancer drug development. It advances innovative cancer vaccine research and development through collaborations with the University of Tokyo and the University of Chicago. The company does not conduct in-house manufacturing but adopts a business model of licensing manufacturing and sales rights to major pharmaceutical companies, securing stable contract income. Research facilities are located in Kanagawa Science Park and King's Skyfront in Kawasaki City, Kanagawa Prefecture, with cutting-edge pharmaceutical development environments. Moving forward, it aims for growth through expansion of partnerships and technological innovations in new drug development, planning commercialization of multiple therapies in the late 2020s. In terms of sustainability, it focuses on pharmaceutical safety and ethical compliance, while also promoting community collaborations and social contribution activities. In the competitive bio drug discovery field, it is working to establish a competitive advantage based on its high technological capabilities.

Trivia

Interesting Facts

  • Drug discovery venture spun out from the University of Tokyo's Institute of Medical Science
  • Founder is a professor at the same institute with significant influence domestically and internationally
  • Business model of not manufacturing pharmaceuticals in-house but consigning to pharma companies
  • One of the few companies continuing international joint research with the University of Chicago
  • Top-tier patent holdings in cancer vaccine field within the industry
  • Base located in Kanagawa Prefecture's science and technology special zone
  • Speed in immediately converting research outcomes to licensing contracts
  • Research facilities consolidated in King's Skyfront
  • Possesses domestically top-class gene analysis technology
  • Yusuke Nakamura holds over 8% of shares as a specific shareholder
  • Pioneer among university-spun ventures listed on Tokyo Stock Exchange Growth Market
  • Business foundation supported by transaction relationships with several major pharmaceutical companies
  • Stable management base over 20 years since founding
  • Head office relocation to Higashida-machi, Kawasaki-ku due to facility modernization
  • Diversified expansion into reagents and analysis services beyond pharmaceuticals

Hidden Connections

  • International joint research with University of Chicago accelerates US clinical trials
  • Risk diversification achieved by consigning manufacturing and sales to major pharmaceutical companies
  • Utilizes research network of University of Tokyo's Institute of Medical Science
  • Contributes to formation of Kawasaki City's medical and science technology cluster
  • Management of drug discovery-related patents is key to business revenue
  • Cancer vaccine manufacturing rights contracts are a rare structure in the industry
  • While specialized in R&D, also deploying diverse bio products
  • Oncovex in view for therapeutic drug deployment domestically and internationally

Future Outlook

Growth Drivers

  • Global increase in demand for cancer immunotherapy
  • Technological innovations in gene pharmaceuticals
  • Expansion of joint research with pharmaceutical companies
  • Improved drug discovery efficiency through AI utilization
  • Advancement of international clinical trials
  • Enhanced research capabilities through securing advanced talent
  • Progress in developing new target molecules
  • Regulatory easing and shortened pharmaceutical approval periods
  • Stabilization of licensing revenues
  • Expanding societal expectations for sustainable medical technologies
  • Support from Kanagawa Prefecture's science and technology policies
  • Strengthening of global partnerships

Strategic Goals

  • Launch several types of cancer treatment drugs to market
  • Expand overseas market sales ratio to over 50%
  • Halve drug discovery time using AI technology
  • Double the number of partnerships with major pharmaceutical companies
  • Obtain international certifications for sustainability and ethical research
  • Global deployment of clinical trial bases
  • Improve employee diversity by over 50%
  • Maintain R&D expenses at 40% of sales
  • Expand and strengthen intellectual property portfolio
  • Enhance corporate value through coexistence with local communities

Business Segments

Drug Discovery Research Support

Overview
Provides gene-related technologies and research support services necessary for pharmaceutical development to promote drug discovery for contract partners.
Competitiveness
Advanced gene analysis technology and research capabilities through university collaborations
Customers
  • Major pharmaceutical companies
  • Biotech ventures
  • University research institutions
  • Public research institutes
  • Contract research organizations
  • Medical device manufacturers
  • Pharmaceutical development companies
  • Diagnostic drug manufacturers
  • Formulation manufacturers
  • CRO (Contract Research Organizations)
Products
  • Gene analysis services
  • Gene probe development
  • Bio reagents
  • Pathology analysis support
  • Data analysis via software
  • Drug discovery platform provision
  • Provision of molecular targeted drug candidates
  • Vaccine design support

Pharmaceutical Development Licensing

Overview
Licenses in-development pharmaceuticals to pharmaceutical companies to support market deployment of therapeutic drugs.
Competitiveness
Product development capabilities utilizing unique university-originated technologies
Customers
  • Domestic pharmaceutical companies
  • Overseas pharmaceutical companies
  • Generic drug manufacturers
  • Medical institutions
  • CRO companies
Products
  • Therapeutic vaccine development results
  • Exclusive manufacturing and sales rights
  • Technology transfer contracts
  • Joint research contracts

Research and Development Equipment and Materials Provision

Overview
Segment providing equipment and materials for drug discovery and diagnostic research to research institutions.
Competitiveness
Customization capabilities for specialized reagents
Customers
  • Universities
  • Research institutes
  • Pharmaceutical company R&D departments
  • Bio labs
Products
  • Gene analysis reagents
  • Cell culture-related materials
  • Diagnostic test kits
  • Biosensors

Joint Research Operations

Overview
Promotes joint research with academic institutions and industry, focusing on foundational research for new pharmaceuticals.
Competitiveness
Research system led by university professors and diverse partnerships
Customers
  • Universities
  • Public research institutions
  • Pharmaceutical companies
  • Medical institutions
Products
  • Joint vaccine development
  • Gene technology research
  • Verification of new therapies
  • Joint management of intellectual property

Data Analysis and IT Services

Overview
Provision of drug discovery support data analysis services utilizing the latest IT technologies.
Competitiveness
Expertise in AI and data analysis technologies
Customers
  • Pharmaceutical companies
  • Research institutions
  • Biotech ventures
  • CROs
Products
  • Drug discovery data integration platform
  • AI analysis services
  • Bioinformatics
  • Research tool provision

Intellectual Property Management

Overview
Supports technology commercialization and business through intellectual property management and distribution.
Competitiveness
Extensive patent portfolio and negotiation capabilities
Customers
  • Pharmaceutical companies
  • Research institutions
  • Investors
  • Partner companies
Products
  • Patent management
  • Technology transfer licensing
  • Technology evaluation
  • Contract negotiation support

Overseas Partnership Operations

Overview
Advances global expansion strategies through collaborations with overseas institutions.
Competitiveness
Track record of collaborations with prestigious overseas institutions like the University of Chicago
Customers
  • Overseas pharmaceutical companies
  • Foreign investment firms
  • International academic institutions
Products
  • International joint research
  • Overseas sales licensing
  • Technology export
  • Market research

Clinical Trial Support Services

Overview
Provides clinical trial support services in new drug development stages, contributing to swift approvals.
Competitiveness
Evaluation system utilizing advanced gene analysis technology
Customers
  • Pharmaceutical companies
  • CROs
  • Medical institutions
Products
  • Clinical trial data analysis
  • Patient recruitment support
  • Clinical trial protocol development

Medical Education Support

Overview
Implements education support and awareness activities for medical professionals.
Competitiveness
High-quality education programs in collaboration with experts
Customers
  • Medical institutions
  • Universities
  • Medical professional associations
Products
  • Seminar hosting
  • Provision of teaching materials
  • Training for specialists

Diagnostic Technology Development

Overview
Supports development and commercialization of new diagnostic technologies.
Competitiveness
Advancement of diagnostic technologies linked with drug discovery
Customers
  • Testing equipment manufacturers
  • Medical institutions
  • Research institutes
Products
  • Gene testing technology
  • Immunodiagnostic kits
  • Biosensor development

Technology Consulting

Overview
Provides consulting services on technical and business aspects.
Competitiveness
Practical proposals leveraging industry knowledge
Customers
  • Biotech companies
  • Pharmaceutical companies
  • Investment institutions
Products
  • Technology evaluation reports
  • Business strategy formulation support
  • Technology introduction support

Manufacturing Outsourcing Management

Overview
Deploys services managing product manufacturing in collaboration with outsourcing partners.
Competitiveness
Strong trusted relationships with outsourcing partners
Customers
  • Major pharmaceutical companies
  • Biotech companies
Products
  • Manufacturing outsourcing contract management
  • Quality control guidance

Competitive Advantage

Strengths

  • Advanced gene analysis technological capabilities
  • Long-term joint research framework with universities
  • Specialized cancer treatment drug development capabilities
  • Management focused on biopharmaceutical drug discovery
  • Track record of partnerships with major pharmaceutical companies
  • Clear separation of R&D and licensing
  • Base in Kawasaki City's advanced research facilities
  • Strong patent portfolio for technology transfer
  • Founder's researcher network
  • Proprietary vaccine platform
  • Adoption of flexible business model
  • Access to domestic and international markets
  • Diversified R&D fields
  • High personnel quality through specialized staff
  • Rapid commercialization system for research outcomes

Competitive Advantages

  • Possesses cutting-edge research technologies through university collaborations
  • Reliably links contract revenues with pharmaceutical companies
  • Unique technological accumulation in vaccine therapy field
  • Established position in domestic biopharmaceutical drug discovery market
  • Combines diverse products and services
  • Strong management capabilities for patents and intellectual property
  • Supportive environment from Kawasaki's science and technology hub
  • Deepens expertise by specializing in cancer treatment field
  • Grasps global trends through international joint research
  • Diversified and stable funding
  • Securing and development of high-caliber R&D personnel
  • Risk diversification through licensing
  • Rapid market entry and promotion of external collaborations
  • Drug discovery data analysis capabilities using advanced IT
  • Cost-efficient operations through manufacturing outsourcing

Threats

  • Intense research competition in biopharmaceutical drug discovery
  • Risk of development failure for new technologies
  • Impact from policy changes by major pharmaceutical companies
  • Complexity and delays in pharmaceutical approvals
  • Impact from fluctuations in funding environment
  • Burden of adapting to international regulations and legal amendments
  • Rapid changes in market needs
  • Patent dispute risks
  • Large-scale investments and resource mobilization by competitors
  • Uncertainty from external environments like emerging infectious diseases
  • Challenges in commercializing research outcomes
  • Decline in technological capabilities due to talent outflow

Innovations

2023: Strengthened Joint Research with University of Chicago

Overview
After recruiting Professor Yusuke Nakamura, advanced cancer vaccine research and progressed to clinical trial stages in the US.
Impact
Promotes product commercialization through expansion of global clinical trials

2022: Development of Next-Generation Cancer Immunotherapy Technology

Overview
Built a vaccine platform combined with immune checkpoint inhibitors.
Impact
Establishes foundation for improved treatment efficacy and new market creation

2024: Introduction of AI Drug Discovery Data Analysis System

Overview
Developed a new system to accelerate gene analysis and drug candidate exploration using AI technology.
Impact
Achieved reduction in R&D period and costs

2021: Concluded Joint Manufacturing Contract with Major Pharma

Overview
Achieved resource efficiency and sales channel expansion through contract specialized in manufacturing and sales with a major company.
Impact
Secures stable revenue and enhances market competitiveness

2020: Development of Gene-Related Marker Testing Technology

Overview
Advanced productization of gene marker test kits supporting early cancer detection.
Impact
Monetizes diagnostic technology field

Sustainability

  • Thorough safety and quality management in pharmaceutical manufacturing
  • Conduct of ethical medical research
  • Promotion of local medical support activities
  • Improvement of energy efficiency
  • Promotion of diversity and inclusion
  • Ensuring transparency of research outcomes
  • Operation of research bases aiming to reduce environmental impact
  • Ensuring employee health and safety
  • Proper management of intellectual property rights
  • Support for local science education
  • CO2 reduction through remote work introduction
  • Strengthening environmental considerations in supply chain